PRELUDE CAPITAL MANAGEMENT, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$22,000
-74.4%
1,046
-71.3%
0.00%
-80.0%
Q2 2020$86,000
-72.1%
3,642
-60.8%
0.01%
-66.7%
Q2 2019$308,000
+11.2%
9,300
+17.7%
0.02%
-6.2%
Q1 2019$277,000
+182.7%
7,900
+168.0%
0.02%
+128.6%
Q4 2018$98,000
-91.4%
2,948
-86.9%
0.01%
-89.4%
Q3 2018$1,133,000
+92.0%
22,500
+128.2%
0.07%
+78.4%
Q2 2018$590,000
+34.7%
9,860
+3.0%
0.04%
+15.6%
Q1 2018$438,000
+25.1%
9,574
+9.1%
0.03%
+14.3%
Q4 2017$350,000
+35.1%
8,774
+35.4%
0.03%
+21.7%
Q3 2017$259,000
-7.2%
6,4780.0%0.02%
-11.5%
Q2 2017$279,000
-6.7%
6,478
-32.1%
0.03%
-10.3%
Q1 2017$299,000
+68.0%
9,545
+35.3%
0.03%
+31.8%
Q4 2016$178,000
-52.0%
7,057
-52.9%
0.02%
-43.6%
Q3 2016$371,000
+50.8%
14,998
+24.1%
0.04%
+14.7%
Q2 2016$246,000
-19.1%
12,081
-39.4%
0.03%
-19.0%
Q1 2016$304,000
+114.1%
19,927
+88.0%
0.04%
+90.9%
Q4 2015$142,000
+195.8%
10,600
+211.8%
0.02%
+214.3%
Q3 2015$48,000
-23.8%
3,400
-8.1%
0.01%
-22.2%
Q2 2015$63,000
-10.0%
3,700
-36.2%
0.01%
-10.0%
Q1 2015$70,000
-58.1%
5,800
-71.1%
0.01%
-58.3%
Q4 2014$167,00020,1000.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders